Watts Gwilliam & Co., LLC Amgen Inc Transaction History
Watts Gwilliam & Co., LLC
- $569 Million
- Q2 2025
A detailed history of Watts Gwilliam & Co., LLC transactions in Amgen Inc stock. As of the latest transaction made, Watts Gwilliam & Co., LLC holds 18,933 shares of AMGN stock, worth $5.51 Million. This represents 0.93% of its overall portfolio holdings.
Number of Shares
18,933
Previous 17,740
6.72%
Holding current value
$5.51 Million
Previous $5.53 Million
4.34%
% of portfolio
0.93%
Previous 1.11%
Shares
5 transactions
Others Institutions Holding AMGN
# of Institutions
3,285Shares Held
440MCall Options Held
6.25MPut Options Held
7.38M-
Vanguard Group Inc Valley Forge, PA53.7MShares$15.6 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY46MShares$13.4 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.4MShares$8.55 Billion0.32% of portfolio
-
Capital International Investors Los Angeles, CA18.9MShares$5.51 Billion0.95% of portfolio
-
Capital World Investors Los Angeles, CA16.9MShares$4.91 Billion0.71% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $156B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...